• LAST PRICE
    3.2500
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    2.1000/ 1
  • Ask / Lots
    3.6500/ 1
  • Open / Previous Close
    0.0000 / 3.2500
  • Day Range
    ---
  • 52 Week Range
    Low 1.7700
    High 14.7890
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 3.42
TimeVolumeVRCA
09:32 ET19963.4637
09:38 ET1003.46
09:57 ET1003.435
10:01 ET2003.41
10:08 ET4903.4055
10:10 ET5003.3913
10:12 ET2003.37
10:14 ET71783.34
10:17 ET3203.3
10:19 ET46993.302
10:21 ET5003.3
10:28 ET2003.29
10:30 ET3003.283
10:32 ET6503.2819
10:37 ET1003.29
10:46 ET11243.27
10:50 ET7653.25
10:51 ET1003.25
10:53 ET4003.24
10:57 ET1503.2534
11:02 ET11003.255
11:04 ET35003.3
11:06 ET1753.32
11:31 ET7003.3
11:33 ET1003.31
11:42 ET10003.29
11:44 ET1003.3
12:05 ET7003.3
12:09 ET23573.3012
12:18 ET6243.3
12:20 ET1003.29
12:27 ET21083.28
12:30 ET12883.27
12:32 ET21873.24
12:34 ET29573.23
12:48 ET3003.2281
12:50 ET1003.25
12:52 ET1003.225
12:54 ET8003.2156
12:57 ET3503.2014
12:59 ET1003.2131
01:01 ET2513.23
01:03 ET1003.2452
01:10 ET2003.24
01:19 ET19003.21
01:24 ET1003.21
01:26 ET1003.22
01:48 ET1563.21
01:50 ET1003.22
01:51 ET19703.22
02:00 ET1003.2493
02:04 ET1003.23
02:18 ET1003.23
02:22 ET1003.23
02:42 ET5003.2499
02:44 ET1003.23
02:45 ET9003.225
02:49 ET1003.21
03:09 ET3003.23
03:14 ET1003.22
03:16 ET1003.24
03:21 ET4233.24
03:25 ET1003.26
03:34 ET1003.25
03:41 ET3633.26
03:45 ET3003.26
03:48 ET2003.26
03:50 ET1003.26
03:52 ET1003.27
03:54 ET7003.27
03:56 ET1003.28
03:57 ET1003.275
03:59 ET9003.25
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVRCA
Verrica Pharmaceuticals Inc
128.4M
-2.1x
---
United StatesGLS
Gelesis Holdings Inc
104.3M
-0.6x
---
United StatesSCYX
SCYNEXIS Inc
88.0M
-2.2x
---
United StatesUG
United-Guardian Inc
72.9M
16.6x
+12.54%
United StatesPYPD
PolyPid Ltd
115.1M
-2.4x
---
United StatesHOOK
HOOKIPA Pharma Inc
84.2M
-0.7x
---
As of 2022-08-10

Company Information

Verrica Pharmaceuticals Inc. is a dermatology therapeutics company. The Company is focused on developing and commercializing treatments for skin diseases. The Company's lead product candidate, VP-102, is a drug-device combination of its topical solution of cantharidin, a widely recognized, naturally sourced agent to treat topical dermatological conditions, administered through its single-use precision applicator. It is developing VP-102 for the treatment of molluscum contagiosum (molluscum), a highly contagious and primarily pediatric viral skin disease, external genital warts and common warts. It also intends to develop its second cantharidin-based product candidate, VP-103, for the treatment of plantar warts, which are warts located on the bottom of the foot. It also intends to develop its third product candidate, LTX-315, for the treatment of dermatological oncology indications, including non-metastatic melanoma and non-metastatic Merkel cell carcinoma.

Contact Information

Headquarters
10 N High St Ste 200WEST CHESTER, PA, United States 19380-3014
Phone
484-453-3300
Fax
302-636-5454

Executives

Chairman of the Board
Paul Manning
President, Chief Executive Officer, Director
Ted White
Chief Financial Officer
P. Terence Kohler
General Counsel, Chief Legal Officer
Christopher Hayes
Chief Commercial Officer
Joe Bonaccorso

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$128.4M
Revenue (TTM)
$431.0K
Shares Outstanding
39.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.16
EPS
$-1.55
Book Value
$1.18
P/E Ratio
-2.1x
Price/Sales (TTM)
298.0
Price/Cash Flow (TTM)
---
Operating Margin
-8,904.64%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.